Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Ischemic Heart Disease

Free Subscription Articles published in J Cardiovasc Pharmacol Retrieve available abstracts of 44 articles: HTML format

Single Articles

April 2008
1. THOMAS D , Giugliano RP
   Antiplatelet Therapy in Early Management of Non-ST-Segment Elevation Acute Coronary Syndrome: The 2002 and 2007 Guidelines From North America and Europe.
   J Cardiovasc Pharmacol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. NAKAMURA T , Obata JE, Kitta Y, Takano H, et al
   Rapid stabilization of vulnerable carotid plaque within 1 month of pitavastatin treatment in patients with acute coronary syndrome.
   J Cardiovasc Pharmacol. 2008;51:365-71.
   PubMed     Related articles    Abstract available
   
   
   
3. BILLMAN GE , Kukielka M
   Novel Transient Outward and Ultra-rapid Delayed Rectifier Current Antagonist, AVE0118, Protects Against Ventricular Fibrillation Induced by Myocardial Ischemia.
   J Cardiovasc Pharmacol. 2008;51:352-8.
   PubMed     Related articles    Abstract available
   
   
   
4. ABDEL-MAKSOUD M , Sazonov V, Gutkin SW, Hokanson JE, et al
   Effects of Modifying Triglycerides and Triglyceride-rich Lipoproteins on Cardiovascular Outcomes.
   J Cardiovasc Pharmacol. 2008;51:331-351.
   PubMed     Related articles    Abstract available
   
   
   March 2008
5. MAEDA Y , Mitsumizo S, Guo F, Kishi H, et al
   Sivelestat Relaxes Porcine Coronary Artery via Inhibition of Ca2+ Sensitization Induced by a Receptor Agonist.
   J Cardiovasc Pharmacol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. ISHIBASHI Y , Takahashi N, Tokumaru A, Karino K, et al
   Effects of Long-term Nicorandil Administration on Endothelial Function, Inflammation, and Oxidative Stress in Patients Without Coronary Artery Disease.
   J Cardiovasc Pharmacol. 2008;51:311-316.
   PubMed     Related articles    Abstract available
   
   
   February 2008
7. KAWANO H , Kawano T, Tanaka K, Eguchi S, et al
   Effects of Dopamine on ATP-Sensitive Potassium Channels in Porcine Coronary Artery Smooth-Muscle Cells.
   J Cardiovasc Pharmacol. 2008;51:196-201.
   PubMed     Related articles    Abstract available
   
   
   January 2008
8. ZIMARINO M , Sacchetta D, Renda G, De Caterina R, et al
   Facilitated PCI: rationale, current evidence, open questions, and future directions.
   J Cardiovasc Pharmacol. 2008;51:3-10.
   PubMed     Related articles    Abstract available
   
   
   December 2007
9. THAI H , Guarraia D, Johnson N, Goldman S, et al
   Valsartan Therapy in Heart Failure After Myocardial Infarction: The Role of Endothelial Dependent Vasorelaxation.
   J Cardiovasc Pharmacol. 2007;50:703-707.
   PubMed     Related articles    Abstract available
   
   
   
10. CHEVALIER P , Dubieff AD, Piqueras E, Pineau J, et al
    The Impact of Acute Myocardial Ischemia on the Ventricular Defibrillation Threshold During Chronic Oral Azimilide Therapy.
    J Cardiovasc Pharmacol. 2007;50:629-632.
    PubMed     Related articles    Abstract available
    
    
    
11. KUHN H , Chaitidis P, Roffeis J, Walther M, et al
    Arachidonic Acid metabolites in the cardiovascular system: the role of lipoxygenase isoforms in atherogenesis with particular emphasis on vascular remodeling.
    J Cardiovasc Pharmacol. 2007;50:609-20.
    PubMed     Related articles    Abstract available
    
    
    
12. JAMNICKI-ABEGG M , Weihrauch D, Chiari PC, Krolikowski JG, et al
    Diabetes abolishes sildenafil-induced cGMP-dependent protein kinase-I expression and cardioprotection.
    J Cardiovasc Pharmacol. 2007;50:670-6.
    PubMed     Related articles    Abstract available
    
    
    
13. TSUKADA YT , Sanna MG, Rosen H, Gottlieb RA, et al
    S1P1-selective agonist SEW2871 exacerbates reperfusion arrhythmias.
    J Cardiovasc Pharmacol. 2007;50:660-9.
    PubMed     Related articles    Abstract available
    
    
    November 2007
14. GROSJEAN N , Vie B, Letienne R, Grand BL, et al
    Effects of SM-20550 Against Myocardial Infarction-induced Arrhythmias, Late Infarct Expansion, and Left Ventricular Dysfunction.
    J Cardiovasc Pharmacol. 2007;50:563-70.
    PubMed     Related articles    Abstract available
    
    
    
15. FUNK CD , Fitzgerald GA
    COX-2 Inhibitors and Cardiovascular Risk.
    J Cardiovasc Pharmacol. 2007;50:470-479.
    PubMed     Related articles    Abstract available
    
    
    
16. FEINMARK SJ
    Arachidonic Acid metabolites in the cardiovascular system.
    J Cardiovasc Pharmacol. 2007;50:467-9.
    PubMed     Related articles   
    
    
    
17. DI NAPOLI P , Di Giovanni P, Gaeta MA, Taccardi AA, et al
    Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
    J Cardiovasc Pharmacol. 2007;50:585-9.
    PubMed     Related articles    Abstract available
    
    
    
18. TRAUPE T , Keller M, Fojtu E, Bhattacharya I, et al
    Antioxidant activity and sex differences of acute vascular effects of amiodarone in advanced atherosclerosis.
    J Cardiovasc Pharmacol. 2007;50:578-84.
    PubMed     Related articles    Abstract available
    
    
    
19. STRAINO S , Salloum FN, Baldi A, Ockaili RA, et al
    Protective effects of parecoxib, a cyclo-oxygenase-2 inhibitor, in postinfarction remodeling in the rat.
    J Cardiovasc Pharmacol. 2007;50:571-7.
    PubMed     Related articles    Abstract available
    
    
    
20. MAITRA N , Adamson C, Greer K, Klewer S, et al
    Regulation of Gene Expression in Rats With Heart Failure Treated With the Thyroid Hormone Analog 3,5-Diiodothyropropionic Acid (DITPA) and the Combination of DITPA and Captopril.
    J Cardiovasc Pharmacol. 2007;50:526-534.
    PubMed     Related articles    Abstract available
    
    
    
21. SHI Y , Jiang MT, Su J, Hutchins W, et al
    Mitochondrial big conductance KCa channel and cardioprotection in infant rabbit heart.
    J Cardiovasc Pharmacol. 2007;50:497-502.
    PubMed     Related articles    Abstract available
    
    
    
22. BOYDEN PA , Davies SS, Viswanathan PC, Amarnath V, et al
    Potential role of isoketals formed via the isoprostane pathway of lipid peroxidation in ischemic arrhythmias.
    J Cardiovasc Pharmacol. 2007;50:480-6.
    PubMed     Related articles    Abstract available
    
    
    October 2007
23. CAN C , Erol A, Cnar M, Olukman M, et al
    Therapeutic concentrations of tacrolimus do not interfere with endothelial nitric oxide synthesis in rat thoracic aortas and coronary arteries.
    J Cardiovasc Pharmacol. 2007;50:399-405.
    PubMed     Related articles    Abstract available
    
    
    
24. WAL RM , Harst PV, Wagenaar LJ, Wassmann S, et al
    Angiotensin II Type 2 Receptor Vasoactivity in Internal Mammary Arteries of Patients With Coronary Artery Disease.
    J Cardiovasc Pharmacol. 2007;50:372-379.
    PubMed     Related articles    Abstract available
    
    
    September 2007
25. DAULL P , Jeng AY, Battistini B
    Towards Triple Vasopeptidase Inhibitors for the Treatment of Cardiovascular Diseases.
    J Cardiovasc Pharmacol. 2007;50:247-256.
    PubMed     Related articles    Abstract available
    
    
    
26. JADHAV S , Sattar N, Petrie JR, Cobbe SM, et al
    Reproducibility and repeatability of peripheral microvascular assessment using iontophoresis in conjunction with laser Doppler imaging.
    J Cardiovasc Pharmacol. 2007;50:343-9.
    PubMed     Related articles    Abstract available
    
    
    
27. LIN LL , Liu AJ, Liu JG, Yu XH, et al
    Protective effects of scutellarin and breviscapine on brain and heart ischemia in rats.
    J Cardiovasc Pharmacol. 2007;50:327-32.
    PubMed     Related articles    Abstract available
    
    
    
28. PATTERSON E , Scherlag BJ, Lazzara R, Garrison GL, et al
    Electrophysiologic actions of d,l-sotalol and GLG-V-13 in ischemically injured canine epicardium.
    J Cardiovasc Pharmacol. 2007;50:304-13.
    PubMed     Related articles    Abstract available
    
    
    
29. POLLESELLO P , Papp Z
    The cardioprotective effects of levosimendan: preclinical and clinical evidence.
    J Cardiovasc Pharmacol. 2007;50:257-63.
    PubMed     Related articles    Abstract available
    
    
    August 2007
30. KIM BH , Sandock KD, Robertson TP, Lewis SJ, et al
    Dietary Effects of Structured Lipids and Phytosteryl Esters on Cardiovascular Function in Spontaneously Hypertensive Rats.
    J Cardiovasc Pharmacol. 2007;50:176-186.
    PubMed     Related articles    Abstract available
    
    
    
31. RAIZADA MK , Ferreira AJ
    ACE2: A New Target for Cardiovascular Disease Therapeutics.
    J Cardiovasc Pharmacol. 2007;50:112-119.
    PubMed     Related articles    Abstract available
    
    
    
32. MA G , Ding S, Feng Y, Shen C, et al
    Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
    J Cardiovasc Pharmacol. 2007;50:201-5.
    PubMed     Related articles    Abstract available
    
    
    July 2007
33. JUCKER BM , Doe CP, Schnackenberg CG, Olzinski AR, et al
    PPARdelta Activation Normalizes Cardiac Substrate Metabolism and Reduces Right Ventricular Hypertrophy in Congestive Heart Failure.
    J Cardiovasc Pharmacol. 2007;50:25-34.
    PubMed     Related articles    Abstract available
    
    
    June 2007
34. BOOTH EA , Marchesi M, Knittel AK, Kilbourne EJ, et al
    The Pathway-Selective Estrogen Receptor Ligand WAY-169916 Reduces Infarct Size After Myocardial Ischemia and Reperfusion by an Estrogen Receptor Dependent Mechanism.
    J Cardiovasc Pharmacol. 2007;49:401-407.
    PubMed     Related articles    Abstract available
    
    
    
35. ABBATE A , Salloum FN, Ockaili RA, Fowler AA 3rd, et al
    Improvement of Cardiac Function With Parecoxib, A Cyclo-oxygenase-2 Inhibitor, in a Rat Model of Ischemic Heart Failure.
    J Cardiovasc Pharmacol. 2007;49:416-418.
    PubMed     Related articles    Abstract available
    
    
    
36. BAKER JE , Kozik D, Hsu AK, Fu X, et al
    Darbepoetin alfa protects the rat heart against infarction: dose-response, phase of action, and mechanisms.
    J Cardiovasc Pharmacol. 2007;49:337-45.
    PubMed     Related articles    Abstract available
    
    
    May 2007
37. MARINO F , Guasti L, Cosentino M, Ferrari M, et al
    Angiotensin II type 1 receptor expression in polymorphonuclear leukocytes from high-risk subjects: changes after treatment with simvastatin.
    J Cardiovasc Pharmacol. 2007;49:299-305.
    PubMed     Related articles    Abstract available
    
    
    
38. DONATO M , Dannunzio V, Berg G, Gonzalez G, et al
    Ischemic Postconditioning Reduces Infarct Size by Activation of A1 Receptors and K+ATP Channels in Both Normal and Hypercholesterolemic Rabbits.
    J Cardiovasc Pharmacol. 2007;49:287-292.
    PubMed     Related articles    Abstract available
    
    
    
39. FINIMUNDI HC , Caramori PA, Parker JD
    Effect of diuretic therapy on exercise capacity in patients with chronic angina and preserved left ventricular function.
    J Cardiovasc Pharmacol. 2007;49:275-9.
    PubMed     Related articles    Abstract available
    
    
    
40. WANG X , Zou Y, Sun A, Xu D, et al
    Emodin induces growth arrest and death of human vascular smooth muscle cells through reactive oxygen species and p53.
    J Cardiovasc Pharmacol. 2007;49:253-60.
    PubMed     Related articles    Abstract available
    
    
    April 2007
41. XU HB , Huang ZQ
    Vasorelaxant effects of icariin on isolated canine coronary artery.
    J Cardiovasc Pharmacol. 2007;49:207-13.
    PubMed     Related articles    Abstract available
    
    
    
42. SEREJO FC , Rodrigues LF Jr, da Silva Tavares KC, de Carvalho AC, et al
    Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
    J Cardiovasc Pharmacol. 2007;49:214-20.
    PubMed     Related articles    Abstract available
    
    
    December 2006
43. GU Q , Yang XP, Bonde P, DiPaula A, et al
    Inhibition of TNF-alpha reduces myocardial injury and proinflammatory pathways following ischemia-reperfusion in the dog.
    J Cardiovasc Pharmacol. 2006;48:320-8.
    PubMed     Related articles    Abstract available
    
    
    
44. LIEPINSH E , Vilskersts R, Loca D, Kirjanova O, et al
    Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction.
    J Cardiovasc Pharmacol. 2006;48:314-9.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: